Economic Evaluation of Timely Versus Delayed Use of Tumor Necrosis Factor Inhibitors for Treatment of Psoriatic Arthritis in the US

INTRODUCTION: The present study aimed to evaluate clinical outcomes and costs associated with timely versus delayed use of tumor necrosis factor inhibitors (TNFis) among patients with moderately to severely active psoriatic arthritis (PsA) with and without moderate/severe psoriasis (Ps) from a US pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Strand, Vibeke, Husni, Elaine, Griffith, Jenny, Zhou, Zheng-Yi, Signorovitch, James, Ganguli, Arijit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127966/
https://www.ncbi.nlm.nih.gov/pubmed/27747584
http://dx.doi.org/10.1007/s40744-016-0042-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127966/
https://www.ncbi.nlm.nih.gov/pubmed/27747584
http://dx.doi.org/10.1007/s40744-016-0042-2

Ejemplares similares